Amgen INC (AMGN) — DEFA14A Filings

All DEFA14A filings from Amgen INC. Browse 6 DEFA14A reports with AI-powered summaries and risk analysis.

DEFA14A Filings (6)

Amgen Files Definitive Proxy Statement — Apr 15, 2026 Risk: low
Amgen Inc. filed a Definitive Proxy Statement (DEFA14A) on April 15, 2026, related to the solicitation of proxies for its annual meeting. The filing, with SEC A
Amgen Inc. Files Definitive Proxy Materials — Apr 29, 2025 Risk: low
Amgen Inc. filed a Definitive Additional Materials proxy statement on April 29, 2025. This filing is related to the company's proxy statement and is not a preli
Amgen Files Definitive Proxy Materials — Apr 17, 2025 Risk: low
Amgen Inc. filed a Definitive Additional Materials proxy statement on April 17, 2025. This filing is related to the company's annual meeting and is not a prelim
Amgen Files Proxy Statement for Annual Meeting — May 10, 2024 Risk: low
Amgen Inc. filed a Definitive Proxy Statement (DEFA14A) on May 10, 2024, for its annual shareholder meeting. The filing details the company's governance, execut
Amgen Files Proxy Statement for Annual Meeting — May 3, 2024 Risk: low
Amgen Inc. filed its definitive proxy statement (DEFA14A) on May 3, 2024, for its upcoming annual meeting. The filing details the company's governance, executiv
Amgen Files Proxy Statement for Shareholder Meeting — Apr 26, 2024 Risk: low
Amgen Inc. filed a Definitive Proxy Statement (DEFA14A) on April 26, 2024, for its annual shareholder meeting. The filing outlines the company's governance, exe

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX